Table of Content

1 Genital Herpes Vaccine Market Overview
1.1 Product Overview and Scope of Genital Herpes Vaccine
1.2 Genital Herpes Vaccine Segment by Type
1.2.1 Global Genital Herpes Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Zoster Vaccine Live
1.2.3 Recombinant Zoster Vaccine
1.3 Genital Herpes Vaccine Segment by Application
1.3.1 Global Genital Herpes Vaccine Market Value by Application: (2024-2034)
1.3.2 Male
1.3.3 Female
1.4 Global Genital Herpes Vaccine Market Size Estimates and Forecasts
1.4.1 Global Genital Herpes Vaccine Revenue 2024-2034
1.4.2 Global Genital Herpes Vaccine Sales 2024-2034
1.4.3 Global Genital Herpes Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Genital Herpes Vaccine Market Competition by Manufacturers
2.1 Global Genital Herpes Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Genital Herpes Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Genital Herpes Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Genital Herpes Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Genital Herpes Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genital Herpes Vaccine, Product Type & Application
2.7 Genital Herpes Vaccine Market Competitive Situation and Trends
2.7.1 Genital Herpes Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genital Herpes Vaccine Players Market Share by Revenue
2.7.3 Global Genital Herpes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genital Herpes Vaccine Retrospective Market Scenario by Region
3.1 Global Genital Herpes Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Genital Herpes Vaccine Global Genital Herpes Vaccine Sales by Region: 2024-2034
3.2.1 Global Genital Herpes Vaccine Sales by Region: 2024-2024
3.2.2 Global Genital Herpes Vaccine Sales by Region: 2024-2034
3.3 Global Genital Herpes Vaccine Global Genital Herpes Vaccine Revenue by Region: 2024-2034
3.3.1 Global Genital Herpes Vaccine Revenue by Region: 2024-2024
3.3.2 Global Genital Herpes Vaccine Revenue by Region: 2024-2034
3.4 North America Genital Herpes Vaccine Market Facts & Figures by Country
3.4.1 North America Genital Herpes Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Genital Herpes Vaccine Sales by Country (2024-2034)
3.4.3 North America Genital Herpes Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genital Herpes Vaccine Market Facts & Figures by Country
3.5.1 Europe Genital Herpes Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Genital Herpes Vaccine Sales by Country (2024-2034)
3.5.3 Europe Genital Herpes Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genital Herpes Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Genital Herpes Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Genital Herpes Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Genital Herpes Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Genital Herpes Vaccine Market Facts & Figures by Country
3.7.1 Latin America Genital Herpes Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Genital Herpes Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Genital Herpes Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genital Herpes Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Genital Herpes Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Genital Herpes Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Genital Herpes Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genital Herpes Vaccine Sales by Type (2024-2034)
4.1.1 Global Genital Herpes Vaccine Sales by Type (2024-2024)
4.1.2 Global Genital Herpes Vaccine Sales by Type (2024-2034)
4.1.3 Global Genital Herpes Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Genital Herpes Vaccine Revenue by Type (2024-2034)
4.2.1 Global Genital Herpes Vaccine Revenue by Type (2024-2024)
4.2.2 Global Genital Herpes Vaccine Revenue by Type (2024-2034)
4.2.3 Global Genital Herpes Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Genital Herpes Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Genital Herpes Vaccine Sales by Application (2024-2034)
5.1.1 Global Genital Herpes Vaccine Sales by Application (2024-2024)
5.1.2 Global Genital Herpes Vaccine Sales by Application (2024-2034)
5.1.3 Global Genital Herpes Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Genital Herpes Vaccine Revenue by Application (2024-2034)
5.2.1 Global Genital Herpes Vaccine Revenue by Application (2024-2024)
5.2.2 Global Genital Herpes Vaccine Revenue by Application (2024-2034)
5.2.3 Global Genital Herpes Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Genital Herpes Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Genital Herpes Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 GSK Genital Herpes Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Genital Herpes Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Merck Genital Herpes Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BioNTech
6.3.1 BioNTech Corporation Information
6.3.2 BioNTech Description and Business Overview
6.3.3 BioNTech Genital Herpes Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 BioNTech Genital Herpes Vaccine Product Portfolio
6.3.5 BioNTech Recent Developments/Updates
6.4 Beike Bio
6.4.1 Beike Bio Corporation Information
6.4.2 Beike Bio Description and Business Overview
6.4.3 Beike Bio Genital Herpes Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Beike Bio Genital Herpes Vaccine Product Portfolio
6.4.5 Beike Bio Recent Developments/Updates
6.5 Changsheng Biotechnology
6.5.1 Changsheng Biotechnology Corporation Information
6.5.2 Changsheng Biotechnology Description and Business Overview
6.5.3 Changsheng Biotechnology Genital Herpes Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio
6.5.5 Changsheng Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genital Herpes Vaccine Industry Chain Analysis
7.2 Genital Herpes Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genital Herpes Vaccine Production Mode & Process
7.4 Genital Herpes Vaccine Sales and Marketing
7.4.1 Genital Herpes Vaccine Sales Channels
7.4.2 Genital Herpes Vaccine Distributors
7.5 Genital Herpes Vaccine Customers
8 Genital Herpes Vaccine Market Dynamics
8.1 Genital Herpes Vaccine Industry Trends
8.2 Genital Herpes Vaccine Market Drivers
8.3 Genital Herpes Vaccine Market Challenges
8.4 Genital Herpes Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Genital Herpes Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Genital Herpes Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Genital Herpes Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Genital Herpes Vaccine Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Genital Herpes Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Genital Herpes Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Genital Herpes Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Genital Herpes Vaccine Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Genital Herpes Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Genital Herpes Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genital Herpes Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Genital Herpes Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genital Herpes Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genital Herpes Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Genital Herpes Vaccine Sales by Region (2024-2024) & (K Units)
Table 18. Global Genital Herpes Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Genital Herpes Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Genital Herpes Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Genital Herpes Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Genital Herpes Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Genital Herpes Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Genital Herpes Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Genital Herpes Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Genital Herpes Vaccine Sales by Country (2024-2024) & (K Units)
Table 27. North America Genital Herpes Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Genital Herpes Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Genital Herpes Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Genital Herpes Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Genital Herpes Vaccine Sales by Country (2024-2024) & (K Units)
Table 32. Europe Genital Herpes Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Genital Herpes Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Genital Herpes Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Genital Herpes Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Genital Herpes Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Genital Herpes Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Genital Herpes Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Genital Herpes Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Genital Herpes Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Genital Herpes Vaccine Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Genital Herpes Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Genital Herpes Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Genital Herpes Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Genital Herpes Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Genital Herpes Vaccine Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Genital Herpes Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Genital Herpes Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Genital Herpes Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Genital Herpes Vaccine Sales (K Units) by Type (2024-2024)
Table 51. Global Genital Herpes Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Genital Herpes Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Genital Herpes Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Genital Herpes Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Genital Herpes Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Genital Herpes Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Genital Herpes Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Genital Herpes Vaccine Price (US$/Unit) by Type (2024-2024)
Table 59. Global Genital Herpes Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Genital Herpes Vaccine Sales (K Units) by Application (2024-2024)
Table 61. Global Genital Herpes Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Genital Herpes Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Genital Herpes Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Genital Herpes Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Genital Herpes Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Genital Herpes Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Genital Herpes Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Genital Herpes Vaccine Price (US$/Unit) by Application (2024-2024)
Table 69. Global Genital Herpes Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. GSK Genital Herpes Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Merck Genital Herpes Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. BioNTech Corporation Information
Table 81. BioNTech Description and Business Overview
Table 82. BioNTech Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. BioNTech Genital Herpes Vaccine Product
Table 84. BioNTech Recent Developments/Updates
Table 85. Beike Bio Corporation Information
Table 86. Beike Bio Description and Business Overview
Table 87. Beike Bio Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Beike Bio Genital Herpes Vaccine Product
Table 89. Beike Bio Recent Developments/Updates
Table 90. Changsheng Biotechnology Corporation Information
Table 91. Changsheng Biotechnology Description and Business Overview
Table 92. Changsheng Biotechnology Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Changsheng Biotechnology Genital Herpes Vaccine Product
Table 94. Changsheng Biotechnology Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Genital Herpes Vaccine Distributors List
Table 98. Genital Herpes Vaccine Customers List
Table 99. Genital Herpes Vaccine Market Trends
Table 100. Genital Herpes Vaccine Market Drivers
Table 101. Genital Herpes Vaccine Market Challenges
Table 102. Genital Herpes Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Genital Herpes Vaccine
Figure 2. Global Genital Herpes Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Genital Herpes Vaccine Market Share by Type in 2022 & 2034
Figure 4. Zoster Vaccine Live Product Picture
Figure 5. Recombinant Zoster Vaccine Product Picture
Figure 6. Global Genital Herpes Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Genital Herpes Vaccine Market Share by Application in 2022 & 2034
Figure 8. Male
Figure 9. Female
Figure 10. Global Genital Herpes Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 11. Global Genital Herpes Vaccine Market Size (2024-2034) & (US$ Million)
Figure 12. Global Genital Herpes Vaccine Sales (2024-2034) & (K Units)
Figure 13. Global Genital Herpes Vaccine Average Price (US$/Unit) & (2024-2034)
Figure 14. Genital Herpes Vaccine Report Years Considered
Figure 15. Genital Herpes Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Genital Herpes Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Genital Herpes Vaccine Players: Market Share by Revenue in 2022
Figure 18. Genital Herpes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 19. Global Genital Herpes Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 20. North America Genital Herpes Vaccine Sales Market Share by Country (2024-2034)
Figure 21. North America Genital Herpes Vaccine Revenue Market Share by Country (2024-2034)
Figure 22. United States Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 23. Canada Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Europe Genital Herpes Vaccine Sales Market Share by Country (2024-2034)
Figure 25. Europe Genital Herpes Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. Germany Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. France Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. U.K. Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Italy Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Russia Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Asia Pacific Genital Herpes Vaccine Sales Market Share by Region (2024-2034)
Figure 32. Asia Pacific Genital Herpes Vaccine Revenue Market Share by Region (2024-2034)
Figure 33. China Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Japan Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. South Korea Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. India Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Australia Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. China Taiwan Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Latin America Genital Herpes Vaccine Sales Market Share by Country (2024-2034)
Figure 41. Latin America Genital Herpes Vaccine Revenue Market Share by Country (2024-2034)
Figure 42. Mexico Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Brazil Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Argentina Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Genital Herpes Vaccine Sales Market Share by Country (2024-2034)
Figure 46. Middle East & Africa Genital Herpes Vaccine Revenue Market Share by Country (2024-2034)
Figure 47. Turkey Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. UAE Genital Herpes Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Global Sales Market Share of Genital Herpes Vaccine by Type (2024-2034)
Figure 51. Global Revenue Market Share of Genital Herpes Vaccine by Type (2024-2034)
Figure 52. Global Genital Herpes Vaccine Price (US$/Unit) by Type (2024-2034)
Figure 53. Global Sales Market Share of Genital Herpes Vaccine by Application (2024-2034)
Figure 54. Global Revenue Market Share of Genital Herpes Vaccine by Application (2024-2034)
Figure 55. Global Genital Herpes Vaccine Price (US$/Unit) by Application (2024-2034)
Figure 56. Genital Herpes Vaccine Value Chain
Figure 57. Genital Herpes Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed